SCHEMBL3078874

SCHEMBL3078874

COc1nc(C)cc2c1CCCC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 5/20 0.36
HTR2C P28335 1/20 0.36
STAT3 P40763 1/20 0.36
UHRF1 Q96T88 1/20 0.36
BCHE P06276 3/20 0.35
CHRM1 P11229 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
NOS2 P35228 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GRIN1 Q05586 2/20 0.34
GRIN2A Q12879 2/20 0.34
BRAF P15056 1/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
NLRP3 Q96P20 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25433645 0.80 ACHE (0.39) ACHEHTR2CBCHECHRM1ALDH1A1
SCHEMBL30496070 0.80 ACHE (0.39) ACHEHTR2CBCHECHRM1ALDH1A1
SCHEMBL31128500 0.77 NLRP3 (0.36) ACHEHTR2CBCHECHRM1ALDH1A1
SCHEMBL24842414 0.76 ACHE (0.36) ACHEHTR2CBCHECHRM1NPC1
SCHEMBL20416971 0.76 STAT3 (0.43) ACHESTAT3UHRF1NPC1RAB9A
SCHEMBL31128504 0.75 MEN1 (0.37) ACHEHTR2CBCHECHRM1NOS3
SCHEMBL30041552 0.74 EHMT2 (0.34) ACHEHTR2CBCHECHRM1NPC1
SCHEMBL18510113 0.72 KDM4E (0.44) STAT3UHRF1NPC1RAB9ANOS3
SCHEMBL15233169 0.70 STAT3 (0.39) STAT3UHRF1NPC1RAB9ANOS3
SCHEMBL24156052 0.70 MEN1 (0.43) STAT3UHRF1NPC1RAB9ANOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795278-B2 Substituted tetrahydro-2H-isoquinolin-1-one derivatives, and methods for the production and use thereof SANOFI-AVENTIS DEUTSCHLAND GMBH (US) 2010-09-14 US disclosed
US-20070142430-A1 SUBSTITUTED TETRAHYDRO-2H-ISOQUINOLIN-1-ONE DERIVATIVES, AND METHODS FOR THE PRODUCTION AND USE THEREOF SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142430-A1 SUBSTITUTED TETRAHYDRO-2H-ISOQUINOLIN-1-ONE DERIVATIVES, AND METHODS FOR THE PRODUCTION AND USE THEREOF PARP1, PARP2, PARP11 ACHE 3580/4885HTR2C 399/4885STAT3 2980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.